HealthEquity Inc (HQY)vsMangoceuticals, Inc. Common Stock (MGRX)
HQY
HealthEquity Inc
$82.47
+0.45%
HEALTHCARE · Cap: $7.01B
MGRX
Mangoceuticals, Inc. Common Stock
$0.33
+8.31%
HEALTHCARE · Cap: $5.27M
Smart Verdict
WallStSmart Research — data-driven comparison
HealthEquity Inc generates 281202% more annual revenue ($1.31B vs $466,910). HQY leads profitability with a 16.4% profit margin vs 0.0%. HQY earns a higher WallStSmart Score of 68/100 (B-).
HQY
Strong Buy68
out of 100
Grade: B-
MGRX
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+33.2%
Fair Value
$115.13
Current Price
$82.47
$32.66 discount
Intrinsic value data unavailable for MGRX.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 92.4% YoY
Growing faster than its price suggests
Strong operational efficiency at 21.6%
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
Premium valuation, high expectations priced in
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : HQY
The strongest argument for HQY centers on EPS Growth, PEG Ratio, Operating Margin. Profitability is solid with margins at 16.4% and operating margin at 21.6%. PEG of 0.89 suggests the stock is reasonably priced for its growth.
Bull Case : MGRX
The strongest argument for MGRX centers on Price/Book, Debt/Equity.
Bear Case : HQY
The primary concerns for HQY are P/E Ratio.
Bear Case : MGRX
The primary concerns for MGRX are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
HQY profiles as a mature stock while MGRX is a value play — different risk/reward profiles.
MGRX carries more volatility with a beta of 2.33 — expect wider price swings.
HQY is growing revenue faster at 7.3% — sustainability is the question.
HQY generates stronger free cash flow (102M), providing more financial flexibility.
Bottom Line
HQY scores higher overall (68/100 vs 24/100), backed by strong 16.4% margins. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
HealthEquity Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
HealthEquity, Inc. provides technology-enabled service platforms to consumers and employers in the United States. The company is headquartered in Draper, Utah.
Mangoceuticals, Inc. Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Mangoceuticals, Inc. focuses to develop, market, and sell various men's wellness products and services through a telemedicine platform. The company is headquartered in Dallas, Texas.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?